Literature DB >> 3966012

The association of chorioamnionitis with preterm delivery.

D S Guzick, K Winn.   

Abstract

To ascertain what proportion of preterm deliveries are attributable to the association with chorioamnionitis, the authors examined prospectively the placentas from all 2774 women who delivered at the Johns Hopkins Hospital during 1980. The incidence of preterm delivery was 5.4% (110 of 2027) when neither chorioamnionitis nor premature rupture of membranes (PROM) was present, 11.9% (29 of 243) when chorioamnionitis was present without PROM, and 56.7% (51 of 90) when both chorioamnionitis and PROM were present (P less than .05). Only 27 of 333 cases of histopathologic chorioamnionitis or 8.1% had maternal antepartum fever, and only 11 of 333 or 3.3% had neonatal sepsis. Using logistic regression analysis to control for confounding variables, approximately 25% of the preterm deliveries were statistically attributable to histopathologic chorioamnionitis, occurring either alone or in association with PROM. In light of the infrequency with which histopathologic chorioamnionitis is clinically evident, the strong relationship between histopathologic chorioamnionitis and preterm delivery suggests that occult antepartum infection of the genital tract is an important cause of preterm delivery.

Entities:  

Mesh:

Year:  1985        PMID: 3966012

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  36 in total

1.  Interpretation of amniotic fluid white blood cell count in "bloody tap" amniocenteses in women with symptoms of preterm labor.

Authors:  Sonya S Abdel-Razeq; Irina A Buhimschi; Mert O Bahtiyar; Victor A Rosenberg; Antonette T Dulay; Christina S Han; Erika F Werner; Stephen Thung; Catalin S Buhimschi
Journal:  Obstet Gynecol       Date:  2010-08       Impact factor: 7.661

2.  A toll-like receptor 9 (rs352140) variant is associated with placental inflammation in newborn infants.

Authors:  Vijender Karody; Shawn Reese; Navin Kumar; Jennifer Liedel; Jason Jarzembowski; Venkatesh Sampath
Journal:  J Matern Fetal Neonatal Med       Date:  2015-09-15

3.  Neutrophil extracellular traps in acute chorioamnionitis: A mechanism of host defense.

Authors:  Nardhy Gomez-Lopez; Roberto Romero; Yaozhu Leng; Valeria Garcia-Flores; Yi Xu; Derek Miller; Sonia S Hassan
Journal:  Am J Reprod Immunol       Date:  2017-01-03       Impact factor: 3.886

Review 4.  The role of urogenital tract infections in the etiology of preterm birth: a review.

Authors:  J Martius; T Roos
Journal:  Arch Gynecol Obstet       Date:  1996       Impact factor: 2.344

5.  Subclinical and clinical chorioamnionitis, fetal vasculitis, and risk for preterm birth: A cohort study.

Authors:  Kristin Palmsten; Katharine K Nelson; Louise C Laurent; Soojin Park; Christina D Chambers; Mana M Parast
Journal:  Placenta       Date:  2018-06-06       Impact factor: 3.481

6.  Histologic chorioamnionitis and acute neurologic impairment in premature infants.

Authors:  Sanjiv B Amin; Hongyue Wang
Journal:  J Matern Fetal Neonatal Med       Date:  2010-10

7.  Mononuclear leukocyte infiltrate in extraplacental membranes and preterm delivery.

Authors:  Claudia Holzman; Patricia K Senagore; Jianling Wang
Journal:  Am J Epidemiol       Date:  2013-02-20       Impact factor: 4.897

8.  Amniotic fluid interleukin-8 as a marker for intraamniotic infection.

Authors:  T Puchner; C Egarter; C Wimmer; F Lederhilger; I Weichselbraun
Journal:  Arch Gynecol Obstet       Date:  1993       Impact factor: 2.344

9.  The involvement of human amnion in histologic chorioamnionitis is an indicator that a fetal and an intra-amniotic inflammatory response is more likely and severe: clinical implications.

Authors:  Chan-Wook Park; Kyung Chul Moon; Joong Shin Park; Jong Kwan Jun; Roberto Romero; Bo Hyun Yoon
Journal:  Placenta       Date:  2008-11-28       Impact factor: 3.481

10.  Amniotic fluid interleukin 6 in preterm labor. Association with infection.

Authors:  R Romero; C Avila; U Santhanam; P B Sehgal
Journal:  J Clin Invest       Date:  1990-05       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.